newsfilter
← Latest News
GlobeNewswire·

John Lunger, of Adaptimmune, Joins Genocea Biosciences' Board of Directors

CAMBRIDGE, Mass., March 07, 2022 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc. (NASDAQ:GNCA), a biopharmaceutical company developing next-generation neoantigen immunotherapies, today announced that John Lunger, Chief Patient Supply Officer at Adaptimmu